Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

Table 2 Total daily, basal, and prandial insulin doses at baseline and week 24

Insulin dose	LM25 (N = 80)	IGL (N = 82)
Total daily insulin dose (IU), mean (SD)
Baseline^a	40.0 (19.2)	43.9 (18.8)
Week 24	61.0 (27.6)	60.6 (24.3)
Daily basal insulin dose (IU), mean (SD)
Baseline^a	30.0 (14.4)	39.8 (18.8)
Week 24	45.8 (20.7)	46.3 (20.2)
Daily prandial insulin dose (IU), mean (SD)
Baseline^a	10.0 (4.8)	4.2 (0.8)
Week 24	15.3 (6.9)	14.4 (6.6)

IGL once-daily basal insulin glargine plus once-daily prandial insulin lispro, IU international units, LM25 75 % insulin lispro protamine suspension and 25 % insulin lispro solution, SD standard deviation
^aBaseline in this table is defined as day 1 post-randomization